(Q49161820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Francesco Mori

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Roberto Furlan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Diego Centonze

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Raffaele Mancino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Valeria Studer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Giulia Maria Sancesario

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

A Bergami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Castelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

V De Chiara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

G Mataluni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

V Parisi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

H Kusayanagi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

G Bernardi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C Nucci

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Bernardini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

G Martino

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

15 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1301-1312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Interleukin-17 as a drug target in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Inhibition of cytokine-induced connexin43 hemichannel activity in astrocytes is neuroprotective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

IL-10 promotes neuronal survival following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Neuronal regulation by which microglia enhance the production of neurotrophic factors for GABAergic, catecholaminergic, and cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Axonal loss in normal-appearing white matter in a patient with acute MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Glutamate receptor expression in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Tau, prions and Aβ: the triad of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Optical coherence tomography: a window into the mechanisms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Corticocortical inhibition in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Human motor evoked responses to paired transcranial magnetic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Techniques and mechanisms of action of transcranial stimulation of the human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Optical coherence tomography in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Interleukin-1 and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

DeltaRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Interleukin-1beta-induced brain injury in the neonatal rat can be ameliorated by alpha-phenyl-n-tert-butyl-nitrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Interleukin-1beta enhances nucleotide-induced and alpha-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y(2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Regulation of myeloid cell function through the CD200 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Inhibitory role for GABA in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Molecular basis of glutamate toxicity in retinal ganglion cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

Expression of the Inhibitory CD200 Receptor Is Associated with Alternative Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511410342

21 January 2018

Identifiers

DOI

10.1177/1352458511410342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21677024%20AND%20SRC:MED&resulttype=core&format=json

release_cttebyb4unasxcjyrwkxx2pzn4

5 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cttebyb4unasxcjyrwkxx2pzn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference